These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26479518)

  • 41. Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS).
    Bothos E; Ntoumou E; Kelaidoni K; Roukas D; Drakoulis N; Papasavva M; Karakostis FA; Moulos P; Karakostis K
    J Transl Med; 2021 Apr; 19(1):151. PubMed ID: 33858454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
    van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
    Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
    Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.
    Leeder JS
    Clin Pharmacol Ther; 2015 Feb; 97(2):119-21. PubMed ID: 25670513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deliberations about clinical pharmacogenetic testing in pediatric oncology.
    Issa AM; Aboushawareb SA; Eisenstat DD; Guilcher GM; Liu G; Rassekh SR; Strahlendorf C; Tallen G; Tanoshima R; Carleton B
    Per Med; 2021 Jul; 18(4):399-405. PubMed ID: 33973801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Routine pharmacogenetic testing in clinical practice: dream or reality?
    Grossman I
    Pharmacogenomics; 2007 Oct; 8(10):1449-59. PubMed ID: 17979518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
    Suzuki O; Dong OM; Howard RM; Wiltshire T
    Pharmacogenomics; 2019 Sep; 20(14):1005-1020. PubMed ID: 31559919
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.
    Haga SB; Mills R; Bosworth H
    Patient Educ Couns; 2014 Oct; 97(1):10-5. PubMed ID: 24985359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetics at Scale: An Analysis of the UK Biobank.
    McInnes G; Lavertu A; Sangkuhl K; Klein TE; Whirl-Carrillo M; Altman RB
    Clin Pharmacol Ther; 2021 Jun; 109(6):1528-1537. PubMed ID: 33237584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.